Jane Street
IART icon

Jane Street’s Integra LifeSciences IART Stock Holding History

Jane Street’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,300
Closed -$465K – 9418
2022
Q4 		$465K Buy
+8,300
New +$422K ﹤0.01% 6258
2020
Q4 		– Sell
-10,000
Closed -$472K – 7744
2020
Q3 		$472K Buy
10,000
+3,800
+61% +$181K ﹤0.01% 5232
2020
Q2 		$291K Buy
+6,200
New +$305K ﹤0.01% 5885

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jane Street's IART Position: Q1 2026 in Review

Jane Street reduced its Integra LifeSciences (IART) stake by 19% in Q1 2026, selling an estimated $407K and leaving 163,124 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #5588.

Jane Street first reported a position in IART in Q2 2014 and has held it in 28 quarters since. The position peaked at $11.3M in Q2 2024. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Jane Street held 163,124 shares of Integra LifeSciences worth $1.54M as of Q1 2026.
  • Jane Street sold 37,055 Integra LifeSciences shares in Q1 2026, an estimated $407K.
  • Integra LifeSciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5588 holding.
  • Jane Street first reported a position in Integra LifeSciences in Q2 2014 and has held it in 28 quarters since.
  • Jane Street's Integra LifeSciences position peaked at $11.3M in Q2 2024.
  • 202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.